Physician profile
William A Collignon
NPI 1174587257
$733.89
in general payments reported to CMS, 2019-2025
8 companies · $28.76 in 2025
The $28.76 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.29 · 2022: $279 · 2023: $380 · 2025: $28.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $410.90 | 2022-2025 | Venaseal, Closurefast |
| Bard Peripheral Vascular, INC. | $121.48 | 2021-2022 | |
| Intuitive Surgical, INC. | $94.60 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $47.63 | 2022 | |
| Hartmann USA, INC. | $21.92 | 2021 | |
| Boston Scientific Corporation | $15.00 | 2022 | |
| Tactile Systems Technology INC | $13.06 | 2023 | Flexitouch Plus, Entre Plus |
| Kerecis Limited | $9.30 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Collignon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.